Audiologists in Lake Oswego, OR Accepting Medicare
4 Audiologists found. Showing 1 - 4
 Hearing Rehab Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 16699 Boones Ferry Rd, #110, Lake Oswego, OR 97035 Phone: 303-984-4414 |
 David Andrew Luther, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 16699 Boones Ferry Rd, Suite 110, Lake Oswego, OR 97035 Phone: 503-636-4014 Fax: 503-636-4031 |
Oregon Hearing Rehab Center Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 16699 Boones Ferry Rd Ste 110, Lake Oswego, OR 97035 Phone: 503-636-4014 Fax: 707-570-1367 |
 Dr. Judith B. Belk, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 14674 Rainbow Dr, Lake Oswego, OR 97035 Phone: 503-699-9022 Fax: 503-636-3014 |
News Archive
Pre-deployment insomnia symptoms associated with major mental disorders
A new study from the Perelman School of Medicine at the University of Pennsylvania and the Naval Health Research Center has shown Military service members who have trouble sleeping prior to deployments may be at greater risk of developing posttraumatic stress disorder (PTSD), depression and anxiety once they return home.
Overweight, obesity and low weight affect teenagers' physical fitness
This research was developed by Dr. Enrique Garcia Artero, from the Department of Physiology of the University of Granada, and coordinated by Professor Manuel J. Castillo Garzón. To carry out this project, the researcher used data from the national and European projects AVENA (Food and Assessment of Nutritional Status of Spanish Adolescents) and HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) and ALPHA (Assessing Levels of Physical Activity and Fitness; Public Health Executive Agency).
Infinity commences enrollment in IPI-493 Phase 1 clinical trial for advanced hematologic malignancies
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
Financial Times analyzes global approaches to debate over family planning
The Financial Times' Andrew Jack analyzes the debate over different approaches to family planning worldwide. According to Jack, there is a "growing worry that some developing countries have failed to follow the broader 'demographic transition' to lower fertility levels that has occurred in past decades in the western world and more recently across Latin America and much of Asia.
Research into hospital bed technology could soon represent giant leap forward in patient care
A University of New Hampshire professor's research into hospital bed technology could soon represent a giant leap forward in patient care.
› Verified 6 days ago
Physical Therapists
Chiropractors
Optometrists
Occupational Therapists
Speech-Language Pathologists
Podiatrists
Audiologists